接受体外受精女性的卵泡液表观遗传年龄加速与卵巢反应标志物
在61名接受体外受精的女性中,采用Horvath时钟评估的卵泡液表观遗传年龄加速与较低峰值雌二醇水平及获卵总数和成熟卵母细胞数减少相关,而GrimAge和颗粒细胞时钟则无此关联。
要点
- Horvath时钟预测的表观遗传年龄加速与峰值雌二醇水平降低及获卵总数和成熟卵母细胞数减少相关。
- GrimAge和颗粒细胞时钟评估的表观遗传年龄加速与卵巢反应标志物无显著关联。
- 卵泡液中特定表观遗传时钟可能预测卵巢刺激结局,但需进一步研究。
核心结论
- 采用Horvath时钟评估的卵泡液表观遗传年龄加速与较低峰值雌二醇水平及获卵总数和成熟卵母细胞数减少相关
- GrimAge和颗粒细胞时钟评估的表观遗传年龄加速与卵巢反应标志物无显著关联
研究设计与样本
- 研究纳入61名在新英格兰地区学术生育诊所接受体外受精的女性,均为环境与生殖健康研究(2006-2016)参与者
- 取卵时采集卵泡液样本,使用全基因组甲基化筛查工具评估DNA甲基化,采用Horvath、GrimAge和颗粒细胞三种表观遗传时钟预测表观遗传年龄
- 通过将表观遗传年龄对实际年龄回归并提取残差计算年龄加速,采用线性回归和泊松回归分析年龄加速与卵巢反应结局的关联,并校正实际年龄、三个替代变量、种族、吸烟状态、初始不孕诊断和刺激方案
主要发现
- 参与者实际年龄中位数为34岁,Horvath时钟预测的表观遗传年龄中位数为24.2岁,GrimAge时钟为38.6岁,颗粒细胞时钟为39.0岁
- Horvath时钟年龄加速每增加一个标准差,峰值雌二醇水平降低819.4单位(95% CI:-1265.7,-373.1)
- Horvath时钟年龄加速每增加一个标准差,获卵总数变化百分比为-21.8%(95% CI:-37.1%,-2.8%),成熟卵母细胞数变化百分比为-23.8%(95% CI:-39.9%,-3.4%)
- 基于GrimAge和颗粒细胞时钟的年龄加速与卵巢反应标志物无显著关联
临床怎么用
- 作者认为特定表观遗传时钟应用于卵泡液时可能预测卵巢刺激结局
- 作者指出特定时钟在不同研究中的不一致发现表明需要进一步研究以更好地理解表观遗传时钟改善体外受精治疗的临床效用
局限性
- 样本量小
- 未从卵泡液样本中专门分离颗粒细胞,样本可能包含混合细胞类型
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are markers of epigenetic age acceleration in follicular fluid associated with outcomes of ovarian stimulation? SUMMARY ANSWER: Increased epigenetic age acceleration of follicular fluid using the Horvath clock, but not other epigenetic clocks (GrimAge and Granulosa Cell), was associated with lower peak estradiol levels and decreased number of total and mature oocytes. WHAT IS KNOWN ALREADY: In granulosa cells, there are inconsistent findings between epigenetic age acceleration and ovarian response outcomes. STUDY DESIGN, SIZE, DURATION: Our study included 61 women undergoing IVF at an academic fertility clinic in the New England area who were part of the Environment and Reproductive Health Study (2006-2016). PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants provided a follicular fluid sample during oocyte retrieval. DNA methylation of follicular fluid was assessed using a genome-wide methylation screening tool. Three established epigenetic clocks (Horvath, GrimAge, and Granulosa Cell) were used to predict DNA-methylation-based epigenetic age. To calculate the age acceleration, we regressed epigenetic age on chronological age and extracted the residuals. The association between epigenetic age acceleration and ovarian response outcomes (peak estradiol levels, follicle stimulation hormone, number of total, and mature oocytes) was assessed using linear and Poisson regression adjusted for chronological age, three surrogate variables (to account for cellular heterogeneity), race, smoking status, initial infertility diagnosis, and stimulation protocol. MAIN RESULTS AND ROLE OF CHANCE: Compared to the median chronological age of our participants (34 years), the Horvath clock predicted, on an average, a younger epigenetic age (median: 24.2 years) while the GrimAge (median: 38.6 years) and Granulosa Cell (median: 39.0 years) clocks predicted, on an average, an older epigenetic age. Age acceleration based on the Horvath clock was associated with lower peak estradiol levels (-819.4 unit decrease in peak estradiol levels per standard deviation increase; 95% CI: -1265.7, -373.1) and fewer total (% change in total oocytes retrieved per standard deviation increase: -21.8%; 95% CI: -37.1%, -2.8%) and mature oocytes retrieved (% change in mature oocytes retrieved per standard deviation increase: -23.8%; 95% CI: -39.9%, -3.4%). The age acceleration based on the two other epigenetic clocks was not associated with markers of ovarian response. LIMITATIONS, REASONS FOR CAUTION: Our sample size was small and we did not specifically isolate granulosa cells from follicular fluid samples so our samples could have included mixed cell types. WIDER IMPLICATIONS OF THE FINDINGS: Our results highlight that certain epigenetic clocks may be predictive of ovarian stimulation outcomes when applied to follicular fluid; however, the inconsistent findings for specific clocks across studies indicate a need for further research to better understand the clinical utility of epigenetic clocks to improve IVF treatment. STUDY FUNDING/COMPETING INTEREST(S): The study was supported by grants ES009718, ES022955, ES000002, and ES026648 from the National Institute of Environmental Health Sciences (NIEHS) and a pilot grant from the NIEHS-funded HERCULES Center at Emory University (P30 ES019776). RBH was supported by the Emory University NIH Training Grant (T32-ES012870). TRIAL REGISTRATION NUMBER: N/A.
引用
- Hood RB, Everson TM, Ford JB, et al. Epigenetic age acceleration in follicular fluid and markers of ovarian response among women undergoing IVF. Hum Reprod. 2024. PMID: 38890131. doi:10.1093/humrep/deae136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。